<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137785">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01803581</url>
  </required_header>
  <id_info>
    <org_study_id>OYS004-0013</org_study_id>
    <nct_id>NCT01803581</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice</brief_title>
  <official_title>A Randomized, Controlled, Investigator-blinded, Comparative Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oystershell NV</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oystershell NV</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy and safety of an insecticide-free head
      lice product with that of a pyrethrum-based product.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>February 2013</start_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>proportion of subjects lice free at the end of the study (Day 10)</measure>
    <time_frame>Day 10</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>the proportion of subjects lice free at each of the intermediate evaluations (Day 1, Day 7)</measure>
    <time_frame>Day 1, Day 7</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>eye irritation</measure>
    <time_frame>Day1, Day7, Day10</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>scalp condition</measure>
    <time_frame>Day0, Day1, Day7, Day10</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Adverse events collection</measure>
    <time_frame>Day1, Day7, Day10</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Head Lice</condition>
  <arm_group>
    <arm_group_label>X92001327</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the X92001327 product is a lotion to be applied on dry hair for 15 minutes and then washed out using shampoo. The product is to be applied on Day 0 and repeated again on Day 7.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RID shampoo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The RID shampoo is to be applied on dry the hair for 10 minutes and then rinsed out with water. the product is to be applied on Day 0 and repeated again on Day 7.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>X92001327</intervention_name>
    <arm_group_label>X92001327</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RID shampoo</intervention_name>
    <arm_group_label>RID shampoo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female over the age of 1 at the time of signing the informed consent or
             giving assent

          -  Have an active head lice infestation of at least 5 live lice and 5 viable nits

          -  subject must be capable of understanding and providing written informed consent

          -  agree not to use any other pediculicides or medicated hair grooming products for the
             duration of the study

          -  agree not to use a lice comb during the study

          -  the parent or guardian of a child must be willing to have other family members
             screened for head lice.

          -  have a single place of residence

        Exclusion Criteria:

          -  used any form of head lice treatment whether prescription or over the counter or home
             remedy at least four weeks prior to their screening visit

          -  used any topical medication of any kind for a period of 48 hours prior to the
             screening visit

          -  individuals on systemic or topical drugs or medications, including systemic
             antibiotics, which in the opinion of the investigative personnel may interfere with
             the study results

          -  has a history of allergy or hypersensitivity to ragweed, hydrocarbons, sesame oil,
             perfume or any ingredient in either test product

          -  individuals with any visible skin/scalp condition at the treatment site which, in the
             opinion of the investigative personnel will interfere with the evaluation of the test
             product

          -  individuals who, in the opinion of the investigative personnel do not understand the
             subject requirements for study participation and/or may be likely to exhibit poor
             compliance with the required visits

          -  females who are pregnant or nursing

          -  patients that have taken trimethoprim or a combination of sulfamethoxazole at
             evaluation or during the previous 4 weeks

          -  subjects with hair longer than mid back
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lidia Serrano</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lice Source Services</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lice Source services Inc</name>
      <address>
        <city>Plantation</city>
        <state>Florida</state>
        <zip>33313</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Barker SC, Burgess I, Meinking TL, Mumcuoglu KY. International guidelines for clinical trials with pediculicides. Int J Dermatol. 2012 Jul;51(7):853-8. doi: 10.1111/j.1365-4632.2011.05446.x.</citation>
    <PMID>22715834</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 1, 2013</lastchanged_date>
  <firstreceived_date>February 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lice Infestations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
